With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

Nondividend payers, such as the fund's positions in Vertex Pharmaceuticals and Royal Caribbean Group, are capped at 5%. While the strategy has excluded alcohol or tobacco companies previously ...

TEDCO, Maryland's economic engine for technology companies, announces its Cyber Maryland Program released the "Maryland's Cybersecurity Talent Strategy" report (Cyber Maryland report). The report, ...

Global drugmakers and MedTech companies bounced back after U.S. President Donald Trump issued a 90-day pause on reciprocal ...

The NICE-Vertex saga continued this month with Vertex ... During the three-hour hearing in Washington, DC, the pharma bosses said that prices had to remain high and pharmacy benefit managers ...

Though pharmaceuticals have been exempt from the tariffs announced ... A group of senators led by Washington Democrat Maria Cantwell and Iowa Republican Charles Grassley is also trying to fight the ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...